Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

3B56

Crystal structure of transthyretin in complex with 3,5-diiodosalicylic acid

Summary for 3B56
Entry DOI10.2210/pdb3b56/pdb
DescriptorTransthyretin, 2-HYDROXY-3,5-DIIODO-BENZOIC ACID (3 entities in total)
Functional Keywordstransthyretin, amyloid inhibitors, iodine, disease mutation, glycoprotein, hormone, polymorphism, polyneuropathy, retinol-binding, secreted, thyroid hormone, transport, vitamin a, transport protein
Biological sourceHomo sapiens (human)
Cellular locationSecreted: P02766
Total number of polymer chains2
Total formula weight28334.55
Authors
Gales, L.,Damas, A.M. (deposition date: 2007-10-25, release date: 2008-01-15, Last modification date: 2023-11-01)
Primary citationGales, L.,Almeida, M.R.,Arsequell, G.,Valencia, G.,Saraiva, M.J.,Damas, A.M.
Iodination of salicylic acid improves its binding to transthyretin
Biochim.Biophys.Acta, 1784:512-517, 2008
Cited by
PubMed Abstract: Transthyretin (TTR) is a plasma homotetrameric protein associated with senile systemic amyloidosis and familial amyloidotic polyneuropathy. In theses cases, TTR dissociation and misfolding induces the formation of amyloidogenic intermediates that assemble into toxic oligomeric species and lead to the formation of fibrils present in amyloid deposits. The four TTR monomers associate around a central hydrophobic channel where two thyroxine molecules can bind simultaneously. In each thyroxine binding site there are three pairs of symmetry related halogen binding pockets which can accommodate the four iodine substituents of thyroxine. A number of structurally diverse small molecules that bind to the TTR channel increasing the protein stability and thereafter inhibiting amyloid fibrillogenesis have been tested. In order to take advantage of the high propensity to interactions between iodine substituents and the TTR channel we have identified two iodinated derivatives of salicylic acid, 5-iodosalicylic acid and 3,5-diiodosalicylic acid, available commercially. We report in this paper the relative binding affinities of salicylic acid and the two iodinated derivatives and the crystal structure of TTR complexed with 3,5-diiodosalicylic acid, to elucidate the higher binding affinity of this compound towards TTR.
PubMed: 18155178
DOI: 10.1016/j.bbapap.2007.11.014
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.55 Å)
Structure validation

237735

数据于2025-06-18公开中

PDB statisticsPDBj update infoContact PDBjnumon